dr. hamdan on the potential use of brentuximab vedotin/nivolumab in hodgkin lymphoma
Published 4 years ago • 175 plays • Length 1:02Download video MP4
Download video MP3
Similar videos
-
0:52
dr. hamdan on trial of brentuximab vedotin/chemo in hiv-associated hodgkin lymphoma
-
1:30
dr. hamdan on choosing among abvd versus a avd in hodgkin lymphoma
-
0:44
dr. hamlin on brentuximab vedotin pharmacology
-
0:59
dr. yasenchak on the safety profile of brentuximab vedotin/nivolumab in hodgkin lymphoma
-
0:51
dr. yasenchak on brentuximb vedotin plus nivolumab in hodgkin lymphoma
-
1:08
nivolumab and brentuximab vedotin with or without bendamustine for r/r hodgkin lymphoma
-
3:23
brentuximab vedotin, nivolumab, doxorubicin & dacarbazine for early stage classical hodgkin lymphoma
-
0:53
alex herrera on nivolumab/brentuximab vedotin combination for patients with hodgkin lymphoma
-
1:59
updates on the use of nivolumab in hodgkin lymphoma & how this agent may impact treatment
-
1:14
brentuximab vedotin combined with nivolumab for hodgkin lymphoma
-
2:18
sgn35-027: brentuximab vedotin with nivolumab, doxorubicin, and dacarbazine in hl
-
1:21
dr. younes discusses fda approval of nivolumab in hodgkin lymphoma
-
0:47
dr. rizvi on brentuximab vedotin plus checkpoint inhibition in hodgkin lymphoma
-
0:54
dr. younes on brentuximab plus avd vs abvd in classical hodgkin lymphoma
-
1:24
dr. kuruvilla on the safety of pembrolizumab in classical hodgkin lymphoma
-
6:59
hodgkin lymphoma: upfront brentuximab vedotin avd
-
2:19
emerging therapeutic options for hodgkin lymphoma
-
1:09
novel immunotherapy combinations in hodgkin lymphoma
-
3:19
the impact of brentuximab vedotin as ptcl treatment